PFIZER INC
PFIZER INC (PFE) is currently classified as Biotechnology within Biotechnology (Healthcare). Classification confidence: 0.81 (rule-based classification). Capital structure on the latest snapshot: total assets 207,618,000,000 USD, total equity 90,101,000,000, short-term debt 3,861,000,000, long-term debt 60,565,000,000. Net cash position is approximately -62,723,000,000 USD. Self-calculated market cap is 147,573,250,000 USD (market_price × shares_outstanding_diluted). Profitability profile: revenue 14,451,000,000, gross profit 0, operating income 0, net income 2,687,000,000. Return on equity ~3.0%. Return on assets ~1.3%. Operating-cash-flow to net-income ratio is 0.97. Risk profile from automated assessment: liquidity risk high, dilution risk medium. Flags: Current ratio is close to the minimum comfort range.; Net cash is negative after subtracting total debt.; Source documents mention dilution or offering risk.. Management commentary signal: purchase the targeted number of shares on the date of executing the accelerated share repurchase agreement..
Business. PFIZER INC is classified under Healthcare / Biotechnology and appears profitable on the latest normalized snapshot.
Classification. Classification confidence is 0.81 based on rule-based classification; matched terms: clinical trial, pipeline.
- Observed GAAP P/E is about 54.92x.
- Return on equity is about 3.0%.
- Debt to equity is about 0.72x.
- Management signal detected: purchase the targeted number of shares on the date of executing the accelerated share repurchase agreement.
- Current ratio is close to the minimum comfort range.
- Net cash is negative after subtracting total debt.
- Source documents mention dilution or offering risk.